Return to Article

Recommend Experimental, living T-cell therapy shows promise, making immunotherapy a ‘pillar’ of cancer care. We speak to Norm Lundell, currently undergoing such treatment. (Email)

This action will generate an email recommending this article to the recipient of your choice. Note that your email address and your recipient's email address are not logged by this system.